Sphera Funds Management »

Generate Biomedicines Ord shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Generate Biomedicines Ord shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3M 185k 12.50

More positions owned by Sphera Funds Management

Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Tower Semiconductor Shs New (TSEM)
Spdr Series Trust State Street Spd Put Option (XBI)
NOVA MEASURING Instruments L (NVMI)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Biogen Idec (BIIB)
Ultragenyx Pharmaceutical (RARE)
Syndax Pharmaceuticals (SNDX)
Cogent Biosciences (COGT)
Sanofi Sa Sponsored Adr (SNY)
Astrazeneca Ord (AZN)
Amicus Therapeutics (FOLD)
Cellebrite Di Ordinary Shares (CLBT)

View all positions for Sphera Funds Management

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
Capital World Investors
Braidwell
Arch Venture Corp
Baker Bros. Advisors
Harvard Management Company
Nvidia Corp
Alyeska Investment Group
ARK Investment Management
Millennium Management
UBS Group
Morgan Stanley
ExodusPoint Capital Management
CenterBook Partners
Sphera Funds Management

View all funds holding Generate Biomedicines Ord